How positive and negative expectations shape the experience of visceral pain: An experimental pilot study in healthy women

Neurogastroenterology and Motility

Volumn 24, Issue 10, 2012, Pages

  Elsenbruch, S ^a   Schmid, J ^a   Basler M ^a   Cesko, E ^a   Schedlowski, M ^a   Benson, S ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anxiety; Cortisol; Expectations; Nocebo; Placebo; Visceral pain

Indexed keywords

HYDROCORTISONE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; AVERSION; COGNITION; CONTROLLED STUDY; DEFECATION; EMOTION; EXPECTATION; EXPERIMENTAL STUDY; FEMALE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; MENTAL STRESS; NOCICEPTION; NORMAL HUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PILOT STUDY; PRIORITY JOURNAL; RECTAL PAIN; STATE TRAIT ANXIETY INVENTORY; VISCERAL PAIN;

ADULT; EMOTIONS; FEMALE; HUMANS; MANOMETRY; PAIN THRESHOLD; PILOT PROJECTS; VISCERAL PAIN; YOUNG ADULT;

EID: 84866284100     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01950.x     Document Type: Article

References (41)

1. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-95.
2. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron 2008; 59: 195-206.
3. Petrovic P. Placebo analgesia and nocebo hyperalgesia-two sides of the same coin? Pain 2008; 136: 5-6.
4. Colloca L, Miller FG. The nocebo effect and its relevance for clinical practice. Psychosom Med 2011; 73: 598-603.
5. Lu CL, Chang FY. Placebo effect in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2011; 26(Suppl. 3): 116-8.
6. Vase L, Norskov KN, Petersen GL, Price DD. Patients' direct experiences as central elements of placebo analgesia. Philos Trans R Soc Lond B Biol Sci 2011; 366: 1913-21.
7. Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 2003; 105: 17-25.
8. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 2005; 115: 338-47.
9. Price DD, Craggs J, Verne GN, Perlstein WM, Robinson ME. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007; 127: 63-72.
10. Elsenbruch S, Kotsis V, Benson S et al. Neural mechanisms mediating the effects of expectation in visceral placebo analgesia: an fMRI study in healthy placebo responders and nonresponders. Pain 2012; 153: 382-90.
11. Lu HC, Hsieh JC, Lu CL et al. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010; 148: 75-83.
12. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil 2008; 20(Suppl. 1): 121-9.
13. Kaptchuk TJ, Kelley JM, Conboy LA et al. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003.
14. Kaptchuk TJ, Friedlander E, Kelley JM et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010; 5: e15591.
15. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience 2007; 147: 260-71.
16. Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010; 59: 489-95.
17. Elsenbruch S, Rosenberger C, Bingel U, Forsting M, Schedlowski M, Gizewski ER. Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology 2010; 139: 1310-9.
18. Rosenberger C, Elsenbruch S, Scholle A et al. Effects of psychological stress on the cerebral processing of visceral stimuli in healthy women. Neurogastroenterol Motil 2009; 21: 740-5.
19. Elsenbruch S. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun 2011; 25: 386-94.
20. Flaten MA, Aslaksen PM, Lyby PS, Bjorkedal E. The relation of emotions to placebo responses. Philos Trans R Soc Lond B Biol Sci 2011; 366: 1818-27.
21. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain 2008; 136: 211-8.
22. Colloca L, Petrovic P, Wager TD, Ingvar M, Benedetti F. How the number of learning trials affects placebo and nocebo responses. Pain 2010; 151: 430-9.
23. van Laarhoven AI, Vogelaar ML, Wilder-Smith OH et al. Induction of nocebo and placebo effects on itch and pain by verbal suggestions. Pain 2011; 152: 1486-94.
24. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry 2008; 65: 220-31.
25. Murray CD, Flynn J, Ratcliffe L, Jacyna MR, Kamm MA, Emmanuel AV. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004; 127: 1695-703.
26. Benson S, Kotsis V, Rosenberger C et al. Behavioural and neural correlates of visceral pain sensitivity in healthy men and women: does sex matter? Eur J Pain 2011; doi: 10.1002/j.1532-2149.2011.00027.x.
27. Sloots CE, Felt-Bersma RJ, Cuesta MA, Meuwissen SG. Rectal visceral sensitivity in healthy volunteers: influences of gender, age and methods. Neurogastroenterol Motil 2000; 12: 361-8.
28. Rosztoczy A, Fioramonti J, Jarmay K, Barreau F, Wittmann T, Bueno L. Influence of sex and experimental protocol on the effect of maternal deprivation on rectal sensitivity to distension in the adult rat. Neurogastroenterol Motil 2003; 15: 679-86.
29. Herrmann-Lingen C, Buss U, Snaith RP. Hospital Anxiety and Depression Scale (HADS) - Deutsche Version (2. Auflage). Bern: Hans Huber, 2005.
30. Spielberger CD, Gorusch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, USA: Consulting Psychology Press, 1970.
31. Price DD, Zhou Q, Moshiree B, Robinson ME, Nicholas Verne G. Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain 2006; 7: 529-35.
32. Bingel U, Lorenz J, Schoell E, Weiller C, Büchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 2006; 120: 8-15.
33. Johansen O, Brox J, Flaten MA. Placebo and Nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med 2003; 65: 786-90.
34. Benedetti F, Amanzio M, Vighetti S, Asteggiano G. The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect. J Neurosci 2006; 26: 12014-22.
35. Kong J, Gollub RL, Polich G et al. A functional magnetic resonance imaging study on the neural mechanisms of hyperalgesic nocebo effect. J Neurosci 2008; 28: 13354-62.
36. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain 1997; 71: 135-40.
37. Price DD, Craggs JG, Zhou Q, Verne GN, Perlstein WM, Robinson ME. Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage 2009; 47: 995-1001.
38. Petrovic P, Dietrich T, Fransson P, Andersson J, Carlsson K, Ingvar M. Placebo in emotional processing-induced expectations of anxiety relief activate a generalized modulatory network. Neuron 2005; 46: 957-69.
39. Coen SJ, Kano M, Farmer AD et al. Neuroticism influences brain activity during the experience of visceral pain. Gastroenterology 2011; 141: 909-17.
40. Aslaksen PM, Bystad M, Vambheim SM, Flaten MA. Gender differences in placebo analgesia: event-related potentials and emotional modulation. Psychosom Med 2011; 73: 193-9.
41. Bingel U, Wanigasekera V, Wiech K et al. The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med 2011; 3: 70ra14.